Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,811 total articles
Lumen ($6.13) is a deeply cyclical telecom that has pivoted to AI-optimized fiber networking. Balance-sheet risk is real, but valuation (market cap $6.3B, EV $17.8B, P/FCF ~7.6) and meaningful free cash flow make a tactical long worth considering for disciplined traders who accept a high probability of volatility.
GlobalFoundries (GFS) looks like a cyclical value play after a sharp pullback from its May highs. The maker of differentiated foundry nodes is showing better margins driven by automotive and communications work, trades at a reasonable market cap of roughly $26.7B, and has technicals that favor a mean-reversion move. This trade is for investors who …
Nano Labs (NA) has stacked a string of tangible developments—an MoU to explore North American AI data centers, a new AI hardware product launch, a compliance-focused blockchain program and a sizeable insider buy. With a $44.6M market cap, a sub-$2 share price and heavy short interest, this is a high-risk, high-reward swing trade for disciplined tra…
10x Genomics has moved from recovery to expansion: a successful product cycle around Atera plus improving margins and positive free cash flow make a tactical long worthwhile. I upgrade the stock to a buy for a long-term trade tied to Atera commercialization milestones, with an explicit entry, stop and target to manage execution risk.
NICE Ltd. combines profitable enterprise software with accelerating AI product adoption and a manageable valuation. Recent weakness from a near-term earnings miss has blown off some optimism; that creates a tradeable opportunity. We outline a long trade with entry at $101, stop at $92 and a $130 target, and explain the catalysts and risks that make…
MercadoLibre just cleared a key cluster of moving averages on higher-than-normal volume while fundamentals still show rapid revenue and free-cash-flow growth. I’m initiating a mid-term swing long on a breakout above recent resistance with a strict stop under the 50-day/EMA support.
Lincoln National (LNC) reported recurring strength in annuities and group protection that has pushed statutory earnings higher, yet the stock trades at a single-digit P/E and below-book valuation. We view LNC as a tactical long for income and value-oriented traders, with a trade plan that captures upside as the market re-rates the insurer while lim…
Iron Mountain is trading lower after a pullback, but data-center colocation and wholesale leasing are driving record revenue growth and should continue to re-rate the company if margins and free cash flow improve. The trade: accumulate on weakness with an entry at $121.50, stop at $114.00, and a primary target of $140.00 over a mid-term to long-ter…
Gates Industrial (GTES) looks set for a mid-term rebound. The business generates meaningful free cash flow ($405M) and trades at roughly 18x earnings and 11x EV/EBITDA; that valuation leaves room for upside if the company converts recent operating gains into sustained margin expansion. We lay out an actionable entry, stop and target with a mid-term…
Texas Pacific Land (TPL) owns irreplaceable surface and royalty rights in the Permian Basin. With a market cap near $25.8B, strong free cash flow of $526.7M, and rising demand for power, water and land from both energy and data-center developers, TPL offers a compelling long-term trade. Entry $373.45, stop $320.00, target $520.00 over the next 180 …
Gold.com, Inc. (GOLD) is a compact, cash-generative alternative-asset platform exposed to rising interest in physical precious metals and collectible coins. With market cap around $1.32B, free cash flow of roughly $207M, and a P/E in the mid-teens, the stock looks positioned for a re-rating if the commodity backdrop and retail demand remain support…
Meta trades like a company priced for flawless execution. That makes the stock vulnerable if the child-safety trial, Reality Labs losses, or ad-growth fatigue bite in H2 2026. I lay out a tactical short: enter at $548.72, stop $605.00, target $430.00, horizon long term (180 trading days). This is a high-risk, high-conviction trade that relies on ne…
AAR (AIR) has delivered accelerating top-line growth, margin expansion and cautious capital deployment that support further upside from current levels. With a $5.6B market cap, manageable leverage and free cash flow generation, the stock offers a mid-term swing opportunity targeting the recent 52-week high and beyond. Entry, stop and target include…
Preformed Line Products (PLPC) is a specialized supplier of hardware for energy and communications networks. After a strong Q2 beat and a 32% U.S. revenue surge, the stock looks attractive on dips given 25% top-line growth, healthy margins, and low leverage. This trade idea targets a tactical long over the next 45 trading days with defined entry, s…
Adobe has posted accelerating revenue and expanding AI-driven ARR while trading at conservative multiples. Fundamentals and cash flow support a swing trade with room to run toward $320 if growth stays on course; protect with a $245 stop.
Avnet's shares have pulled back after a year of weak end-market demand, leaving a valuation that looks full on trailing results but reasonable on an improving next year. The company trades at a $7.25B market cap, EV/EBITDA ~11 and P/E ~21.7 on reported EPS of $4.07. I recommend a long trade sized as part of a diversified portfolio with entry near $…
nVent Electric supplies the guts of data-center power and protection systems. With AI racks demanding higher power density, the company’s electrical connections, PDUs, and enclosures become as critical as cooling. The stock pulled back to $156.93 after recent volatility; earnings strength, a $500M buyback authorization and $577.7M free cash flow cr…
NextEra Energy's pullback is a buying opportunity. The stock trades near $86 with a 2.76% yield, a 52-week range of $69.24-$98.75 and a market cap of ~$179.2B. Growing large-load demand from AI data centers, a meaningful renewables backlog and steady regulated utility cash flows support upside to near-term resistance around $98. This trade idea out…
BHP has been pigeonholed as an iron ore miner for years. That narrative is outdated. With large-scale copper exposure, the ramp of Jansen potash, and exploration moves in Africa, BHP looks set to re-rate. Technical momentum and a still-attractive yield make a structured long trade compelling over the next 45 trading days.
Energy Transfer (ET) offers a compelling entry: buy units at $21.17 for a roughly 6.4% yield on cost, backed by raised 2026 guidance, expanding infrastructure exposure to AI data centers and LNG exports, and an 8.2x EV/EBITDA valuation. Target $24.50 over the next 180 trading days while protecting capital with a $19.00 stop.
Arista posted a $3.036B Q2 and raised guidance to $12.6B, validating its AI networking momentum. Strong margins, $5.16B in free cash flow and zero debt underpin a thesis for multiple expansion. Initiate a long with a $186.46 entry, $240 target and $160 stop for a long-term (180 trading days) trade.
Infosys is trading near its recent lows after a sharp re-rating, but fundamentals and strategic M&A suggest the market has overshot. At $12.03 the stock offers a 3.8% yield, a P/E around 14.5, and an attractive market-cap base of $48.8B. We recommend a disciplined long with a defined entry at $12.00, stop at $10.25 and target of $16.50 over a swing…
Seabridge Gold is a development-stage gold company with sizable long-life projects and a capital structure that can deliver big upside if permitting, financing or a major partner materializes. The stock looks fairly priced for the base case but offers an attractive asymmetric payoff if catalysts hit. This trade idea lays out a concrete entry, prote…
Hanmi Financial (HAFC) is showing steady earnings power, a conservative balance sheet and active capital returns. At roughly $31.15, the shares look positioned for a mid-term re-rating supported by continued buybacks, a raised dividend and low leverage. This trade idea lays out entry, target and stop along with the catalysts and risks that will det…
Trevi Therapeutics (TRVI) is a clinical-stage biotech advancing Haduvio (oral nalbuphine ER) for chronic cough and pruritic conditions. Recent financing and conference activity have tightened the runway and investor attention; valuation is rich given development-stage fundamentals, but positive cough data and heavy short interest create a tacticall…
